Many of the features of modern compliance programs were born out of anti-corruption and anti-bribery efforts. As other risks come to the forefront, what does the future of compliance look like? In a recent conversation, Klaus Moosmayer, chief ethics, risk and compliance officer for Novartis, explained that compliance needs to take a broader view of risk to stay relevant and sustainable in the long run. He discussed how Novartis is implementing a holistic risk assurance framework, and how that has influenced the company’s new code of ethics. See “Using a Code of Conduct to Drive Engagement With Compliance and Ethics” (Mar. 6, 2019).